Recent Finacing
Recent Raise
SpringWorks Therapeutics is a clinical-stage precision-medicine biopharma developing targeted oncology and rare-disease therapies—advancing nirogacestat and MEK/RAF programs into combination studies and pivotal clinical trials with pharma and patient-group partners.
